Phosphorex Appoints Jarlath Keating as Chief Executive Officer
September 19th, 2022 — Following the recent growth capital investment from Ampersand Capital Partners, Phosphorex announced today the appointment of Jarlath Keating as Chief Executive Officer. Learn more
Phosphorex to Establish cGMP Manufacturing for Lipid Nanoparticles with Growth Capital from Ampersand
August 25th, 2022 — Phosphorex, a drug delivery-focused contract development and manufacturing organization providing microspheres and polymer and lipid nanoparticles, today announced a majority recapitalization by Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the healthcare sector. Learn more
Phosphorex and Dolomite Host Collabarative Webinar to Share Their Insights on Making Liposomes and Lipid Nanoparticles (LNPs) with Microfluidics
February 16th, 2022 — Phosphorex & Dolomite experts share their insights about the most important considerations when making liposomes and lipid nanoparticles (LNPs) with microfluidics. Learn more
Phosphorex and Dolomite Jointly Publish Articles to Discuss How Automation Benefits Development and Production of Lipid Nanoparticles (LNPs)
August 11th, 2021 — ONdrugDelivery article to discuss how automation of Lipid Nanoparticles production can benefit the development and manufacture of RNA-based drugs and vaccines. Learn more
Phosphorex Presents Its Nanosuspension Formulation at CRS Meeting
July 27th, 2021 — Phosphorex Presents Its Nanosuspension Formulation at Controlled Release Society Annual Meeting Learn more
Phosphorex and Dolomite Microfluidics Partner to Accelerate Lipid Nanoparticle (LNP) Development
June 3rd, 2021 — Partnership Creates A Powerful Platform for Pharmaceutical Company Clients. Learn more
Phosphorex Expands Facilities
January 7th, 2021 — Phosphorex announced today the acquisition of new laboratory and office space in Hopkinton, MA to meet the increasing demand for its products and services. Learn more
Phosphorex Technologies Showcased at Partnership Opportunities in Drug Delivery (PODD)
October 22nd, 2019 — AstraZeneca Highlights Collaboration with Phosphorex on use of Zetafinity® Technology to More Effectively Target Immune Cells Learn more
Phosphorex Technologies Highlighted at Nanomedicine and Drug Delivery Symposium (NanoDDS’19)
September 22nd, 2019 — Matthew Wingate, Director of Process Development, Described how Phosphorex Accelerates Nanomedicine Development from Proof of Concept to Clinical Trials Learn more
Phosphorex CEO Dr. Bin Wu Nominated for 2019 Barry M. Portnoy Immigrant Entrepreneur Awards
September 16th, 2019 — The Immigrant Learning Center today announced the nominees for the 2019 Barry M. Portnoy Immigrant Entrepreneur Awards Learn more
Phosphorex at the 44th Controlled Release Society Annual Meeting and Exposition in Boston
July 14th, 2017 — Phosphorex, Inc., a leading drug delivery company, today announced its participation in the upcoming Annual Meeting and Exposition of the Controlled Release Society, to be held at the Boston Convention Center, Boston, Massachusetts Learn more
Phosphorex Names Julia Rashba-Step as Vice President, R&D and Alliance Management
July 10th, 2017 — Phosphorex, Inc., a privately held company focused on the development of drug delivery products and technologies, today announced it has named former Pfizer’s Senior Director of Novel Delivery Technologies, Julia Rashba-Step, Ph.D., to the newly created post of Vice President, Research & Development and Alliance Management. Learn more